IGC Pharma | 8-K: Current report
IGC Pharma | 4: Statement of changes in beneficial ownership of securities-Director Moran James P
IGC Pharma | 8-K: Current report
IGC Pharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Bradbury Strategic Investment Fund A(18.3%)
IGC Pharma | 4: Statement of changes in beneficial ownership of securities-Director PRINS RICHARD K
IGC Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144
IGC Pharma | 10-Q: Q1 2025 Earnings Report
IGC Pharma | UPLOAD: Others
IGC Pharma | 8-K: Current report
IGC Pharma | DEFA14A: Others
IGC Pharma | DEF 14A: Definitive information statements
IGC Pharma | 10-K: FY2024 Annual Report
IGC Pharma | SC 13D: Statement of acquisition of beneficial ownership by individuals-Bradbury Strategic Investment Fund A(18.3%)
IGC Pharma | 4: Statement of changes in beneficial ownership of securities-10% Owner Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857)
IGC Pharma | 3: Initial statement of beneficial ownership of securities- Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857)
IGC Pharma | EFFECT: Others
IGC Pharma | CORRESP: CORRESP
IGC Pharma | UPLOAD: Others
IGC Pharma | S-3: Registration statement for specified transactions by certain issuers
IGC Pharma | 8-K: Current report
No Data
No Data